Published May 8, 2024 | Version v1
Presentation Open

Maximizing efficiency in platform trials with shared controls: Optimal allocation strategies and non-concurrent controls

  • 1. ROR icon Medical University of Vienna
  • 1. ROR icon Novartis (Switzerland)
  • 2. ROR icon Janssen (Germany)
  • 3. ROR icon Medical University of Vienna

Description

Presentation for the XIX Spanish Biometric Conference (CEB) and VIII Ibero-American Biometric Meeting (EIB) (in Vigo, 2023), as part of the Ibero-American invited session.

This presentation is based on the work:

Bofill Roig, M., Glimm, E., Mielke, T., & Posch, M. (2024). Optimal allocation strategies in platform trials with continuous endpoints. Statistical Methods in Medical Research33(5), 858-874. https://doi.org/10.1177/09622802241239008

Files

CEB_2023_Vigo_SesionIberoamericana_MBofillRoig.pdf

Files (1.1 MB)

Additional details

Funding

EU-PEARL – EU Patient- cEntric clinicAl tRial pLatform 853966
European Commission